Hamid Yousaif Qureshi: Japanese Scientists Develop Artificial Blood
Hamid Yousaif Qureshi, Expert in Medication Management and Patient-Centric Care, shared a post on LinkedIn:
“Researchers at Nara Medical University in Japan have been developing an experimental artificial blood substitute known as hemoglobin vesicles (HbV).
These are microscopic particles designed to carry oxygen in a way similar to red blood cells.
Each vesicle contains purified hemoglobin enclosed inside a lipid layer that functions like a simplified cell membrane.
One of the key advantages is compatibility. Natural blood must be carefully matched between donor and patient due to surface markers.
These vesicles do not carry those markers, meaning they could potentially be used across different blood types without matching.
Another major benefit is storage.
Donated blood typically lasts around 42 days, while these artificial vesicles can remain stable for much longer under controlled conditions.
This could make them useful in emergencies, disaster response, and areas where blood supply is limited.
However, this technology is still under development.
Natural blood performs many roles beyond oxygen transport, including clotting, immune response, and nutrient delivery.
Current versions of artificial blood are mainly designed to support oxygen delivery in specific situations.
Further research and clinical studies are ongoing to determine safety, effectiveness, and how this technology could be used in real-world medical care.
Source: Nara Medical University – research on hemoglobin vesicles.
Disclaimer: This content is for informational purposes only.
Courtesy:
MedStories.”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders